Global Mechanical Thrombectomy Devices Storage Market - Drivers and Forecasts by Technavio

Technavio has published a new report on the global mechanical thrombectomy devices market from 2017-2021. (Graphic: Business Wire)

LONDON--()--Technavio analysts forecast the global mechanical thrombectomy devices market to grow at a CAGR of more than 6% during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global mechanical thrombectomy devices market for 2017-2021. The market is segmented based on end-user (hospitals and ASCs) and geography (the Americas, EMEA, and APAC).

The mechanical thrombectomy devices market is expected to grow at a steady rate during the forecast period. These devices are the gold standard for the treatment of blood clot and revascularization, despite the higher demand for aspiration and rheolytic thrombectomy devices. Public awareness is rising for the early diagnosis of PAD and related disorders to avoid the further blockage of arteries. Surgeon's preference for the use of mechanical thrombectomy devices is high, due to the ease of use and high success rate.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

Technavio healthcare and life sciences research analysts highlight the following factors that are contributing to the growth of the global mechanical thrombectomy devices market:

  • Rising prevalence of CVDs and cerebrovascular diseases
  • Increasing product approvals and patents
  • Acquisition of small specialized hospitals by Tier-1 hospitals

Rising prevalence of CVDs and cerebrovascular diseases

The rise in prevalent cases of CVDs and cerebrovascular diseases is driving the market growth, with the increased use of thrombectomy devices for the removal of blood clots. Mechanical thrombectomy is one of the conventional products used for the treatment of stroke and CVDs. Some of the common CVDs where blood clots occur are CHDs and PVDs.

Srinivas Sashidhar, a lead cardiovascular devices research analyst at Technavio, says, “According to the CDC, in 2015, VTE cases included PE and DVT. The statistics of VTE cases is difficult to gather, but according to the CDC, about 900,000 people are affected by PE/DVT each year in the US. The higher incidence rate drives the procedure volume and impacts the growth of the market.

Increasing product approvals and patents

Several devices are available in the market to treat CVDs and other related medical conditions. The blockage of arteries is one of the common medical conditions in CVDs. To treat the blockage and the dissolution of thrombus, there are several products in the market for the revascularization and normal blood flow in the arteries. Many product patents are being filed for product approvals and the treatment of thrombosis.

In the US market, Penumbra has launched the latest thrombectomy device, the ACE 68 Reperfusion Catheter. This provides an opportunity to the surgeon to facilitate reverse stroke, which is a cost-effective procedure. In the last quarter of FY2016, the company recorded increased sales of thrombectomy device in the peripheral vascular business segment,” adds Srinivas.

Acquisition of small specialized hospitals by Tier-1 hospitals

The growing trend of acquiring hospitals has helped to increase the patient care management, which has indirectly impacted the growth of the mechanical thrombectomy devices market. Large hospitals acquire smaller ones, which helps to train the healthcare staff, including the physicians and nurses. This helps in the enhancement of their skills and ensures positive outcomes in patient management and diagnosis of PAD.

The presence of skilled professionals for PAD techniques (vascular specialists) and limb amputation in the US has led to an increase in the procedure volumes. The techniques used by healthcare professionals have improved with the increasing number of M&As of hospitals, which helped in the growth of peripheral vascular procedures and mechanical thrombectomy procedures.

Top vendors:

  • Boston Scientific
  • Medtronic
  • Teleflex

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like in-vitro diagnostics, life science research tools, and cardiovascular and metabolic disorders. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

Technavio analysts forecast the global mechanical thrombectomy devices market to grow at a CAGR of more than 6 % during the period 2017-2021.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770